Telesis Bio (NASDAQ:TBIO) just reported results for the fourth quarter of 2023.
- Telesis Bio reported earnings per share of -23 cents. This was below the analyst estimate for EPS of -22 cents.
- The company reported revenue of $6.98 million.
- This was 0.33% worse than the analyst estimate for revenue of $7.00 million.